Dimerix gains NMPA approval for IND, opening doors to global phase three tudy on FSGS Treatment
Dimerix (ASX:DXB) has secured approval from the Chinese National Medical Products Administration…
Change | ||
S&P/ASX Sm. Ords. | |||
All Ordinaries | |||
S&P/ASX 100 |
SRK | STRIKE RESOURCES LIMITED | 6.2¢ | 40.9% |
RCR | RINCON RESOURCES LIMITED | 10.0¢ | 29.9% |
OXT | OREXPLORE TECHNOLOGIES LIMITED | 2.3¢ | 27.8% |
LU7 | LITHIUM UNIVERSE LIMITED | 2.6¢ | 21.2% |
BUR | BURLEY MINERALS LTD | 5.4¢ | 16.9% |
GLN | GALAN LITHIUM LIMITED | 27.5¢ | 16.7% |